Therapy Areas: Cardiovascular
Spectrum Plastics Group closes Earnan Biomedical acquisition
21 June 2019 -

Medical components company Spectrum Plastics Group revealed on Thursday that it has completed the acquisition of Earnan Biomedical Ltd, based in Wexford, Ireland.

Led by Colin Sutherland, Earnan specialises in the design, development and manufacture of custom balloon forming technologies. Its suite of capabilities includes textured and non-textured balloons across a wide variety of materials, including nylon, polyurethane and polyester. Additional developments include multi-layered balloon designs and high-pressure products. Applications range across cardiovascular, gastrointestinal, nutrition, neurovascular, wound care and orthopaedic solutions.

The acquisition of of Earnan represents additional investment for Spectrum Plastics overseas and in Ireland in particular, contributing to its established manufacturing presence and operation in Tullamore.

Spectrum Plastics will retain the Earnan name as the brand under which its balloon solutions will be marketed -- Earnan balloons by Spectrum Plastics Group.

Additionally, Sutherland will remain with Spectrum Plastics as vice president of Balloon Technologies and direct the Wexford, Ireland centre of excellence for balloon innovation, which will become part of Spectrum Plastics' Vascular Technologies division.

Financial terms of the agreement were not disclosed by the companies.

Login
Username:

Password: